210 related articles for article (PubMed ID: 21300096)
1. Room temperature stabilization of oral, live attenuated Salmonella enterica serovar Typhi-vectored vaccines.
Ohtake S; Martin R; Saxena A; Pham B; Chiueh G; Osorio M; Kopecko D; Xu D; Lechuga-Ballesteros D; Truong-Le V
Vaccine; 2011 Mar; 29(15):2761-71. PubMed ID: 21300096
[TBL] [Abstract][Full Text] [Related]
2. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a.
Dharmasena MN; Hanisch BW; Wai TT; Kopecko DJ
Int J Med Microbiol; 2013 Apr; 303(3):105-13. PubMed ID: 23474241
[TBL] [Abstract][Full Text] [Related]
3. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
[TBL] [Abstract][Full Text] [Related]
4. Formulation and stabilization of Francisella tularensis live vaccine strain.
Ohtake S; Martin RA; Saxena A; Lechuga-Ballesteros D; Santiago AE; Barry EM; Truong-Le V
J Pharm Sci; 2011 Aug; 100(8):3076-3087. PubMed ID: 21491457
[TBL] [Abstract][Full Text] [Related]
5. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
[TBL] [Abstract][Full Text] [Related]
6. Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.
Wang JY; Pasetti MF; Noriega FR; Anderson RJ; Wasserman SS; Galen JE; Sztein MB; Levine MM
Infect Immun; 2001 Aug; 69(8):4734-41. PubMed ID: 11447145
[TBL] [Abstract][Full Text] [Related]
7. Improvement of the live vaccine strain Salmonella enterica serovar Typhi Ty21a for antigen delivery via the hemolysin secretion system of Escherichia coli.
Hotz C; Fensterle J; Goebel W; Meyer SR; Kirchgraber G; Heisig M; Fürer A; Dietrich G; Rapp UR; Gentschev I
Int J Med Microbiol; 2009 Feb; 299(2):109-19. PubMed ID: 18706861
[TBL] [Abstract][Full Text] [Related]
8. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
[TBL] [Abstract][Full Text] [Related]
9. Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA.
Galen JE; Zhao L; Chinchilla M; Wang JY; Pasetti MF; Green J; Levine MM
Infect Immun; 2004 Dec; 72(12):7096-106. PubMed ID: 15557633
[TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a.
Cryz SJ; Fürer E; Baron LS; Noon KF; Rubin FA; Kopecko DJ
Infect Immun; 1989 Dec; 57(12):3863-8. PubMed ID: 2807550
[TBL] [Abstract][Full Text] [Related]
11. A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA.
Frey SE; Lottenbach KR; Hill H; Blevins TP; Yu Y; Zhang Y; Brenneman KE; Kelly-Aehle SM; McDonald C; Jansen A; Curtiss R
Vaccine; 2013 Oct; 31(42):4874-80. PubMed ID: 23916987
[TBL] [Abstract][Full Text] [Related]
12. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
13. Development of a Live Attenuated Bivalent Oral Vaccine Against Shigella sonnei Shigellosis and Typhoid Fever.
Wu Y; Chakravarty S; Li M; Wai TT; Hoffman SL; Sim BK
J Infect Dis; 2017 Jan; 215(2):259-268. PubMed ID: 27803169
[TBL] [Abstract][Full Text] [Related]
14. Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.
Baillie LW; Rodriguez AL; Moore S; Atkins HS; Feng C; Nataro JP; Pasetti MF
Vaccine; 2008 Nov; 26(48):6083-91. PubMed ID: 18805452
[TBL] [Abstract][Full Text] [Related]
15. Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.
Osorio M; Wu Y; Singh S; Merkel TJ; Bhattacharyya S; Blake MS; Kopecko DJ
Infect Immun; 2009 Apr; 77(4):1475-82. PubMed ID: 19179420
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of Salmonella typhi Ty21a vaccine for young children.
Murphy JR; Grez L; Schlesinger L; Ferreccio C; Baqar S; Muñoz C; Wasserman SS; Losonsky G; Olson JG; Levine MM
Infect Immun; 1991 Nov; 59(11):4291-3. PubMed ID: 1937790
[TBL] [Abstract][Full Text] [Related]
17. Enhancement by ampicillin of antibody responses induced by a protein antigen and a DNA vaccine carried by live-attenuated Salmonella enterica serovar Typhi.
Woo PC; Tsoi HW; Leung HC; Wong LP; Wong SS; Chan E; Yuen KY
Clin Diagn Lab Immunol; 2000 Jul; 7(4):596-9. PubMed ID: 10882658
[TBL] [Abstract][Full Text] [Related]
18. Reasons for instability of bacterial vaccines.
Corbel MJ
Dev Biol Stand; 1996; 87():113-24. PubMed ID: 8854008
[TBL] [Abstract][Full Text] [Related]
19. Use of the alpha-hemolysin secretion system of Escherichia coli for antigen delivery in the Salmonella typhi Ty21a vaccine strain.
Gentschev I; Dietrich G; Spreng S; Neuhaus B; Maier E; Benz R; Goebel W; Fensterle J; Rapp UR
Int J Med Microbiol; 2004 Oct; 294(6):363-71. PubMed ID: 15595386
[TBL] [Abstract][Full Text] [Related]
20. Genetic stability of vaccine strain Salmonella Typhi Ty21a over 25 years.
Kopecko DJ; Sieber H; Ures JA; Fürer A; Schlup J; Knof U; Collioud A; Xu D; Colburn K; Dietrich G
Int J Med Microbiol; 2009 Apr; 299(4):233-46. PubMed ID: 19121604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]